Research Paper Volume 13, Issue 13 pp 17655—17672
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
Figure 5. Drug sensitivity analysis to drugs of high- and low-risk subgroups. Differential chemotherapeutic responses in high- and low-risk patients (A–X).